I joined Penn State Health Children’s Hospital in 2013, and am now an associate professor of Pediatrics. I also serve as the director of the NICU Neurodevelopmental Follow-Up Clinic, where I oversee the evaluation of former NICU patients who are at risk for abnormal neurodevelopment.
I study long-term health and educational outcomes of infants with neonatal abstinence syndrome/ neonatal opioid withdrawal syndrome. I am funded by the National Institutes of Health (NIH K23 award) and several local foundations. I am also a co-investigator on several NIH-funded research investigations evaluating maternal and infant outcomes in mothers with substance use disorders.
I am involved in several institutional, regional, state and national collaboratives aimed at improving the assessment, treatment and support of families affected by substance use disorders. They include the Penn State ACT Steering Committee, the Dauphin County Safe Plan of Care Committee, the Pennsylvania Perinatal Quality Collaborative, and the American Society of Addiction Medicine’s Public Policy Committee. My ultimate goal is to pursue prospective intervention clinical trials for the improvement of long-term outcomes in infants and children affected by neonatal abstinence syndrome/neonatal opioid withdrawal syndrome.
We accept a variety of health insurance plans and will submit claims on your behalf. Certain coverage restrictions may apply based on your individual benefit package.
Medical School, Philadelphia College of Osteopathic Medicine - 2007
Fellowship, Neonatal-Perinatal Medicine UPMC Children's Hospital of Pittsburgh - 2013
Residency, Pediatrics Geisinger Medical Center (Pennsylvania) - 2010